Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF.

BMC infectious diseases - 27 Nov 2023

Nie Qi, Sun Dan, Zhu Muxin, Tu Shengjin, Chen Nanshan, Chen Hua, Zhou Yong, Yao Ge, Zhang Xiaoqing, Zhang Tongcun, Yang Chengfeng, Tao Lixuan

Abstract excerpt

BACKGROUND: GeneXpert MTB/RIF (Xpert) assay was applied widely to detect Mycobacterium tuberculosis (MTB) and rifampicin resistance. METHODS: Retrospectively investigated the association among treatment histories, phenotypic drug susceptibility testing (pDST) results, and clinical outcomes of patients infected with probe A absent mutation isolate confirmed by Xpert. RESULTS: 63 patients with only probe A absent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microbial Sensitivity Tests
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mycobacterium tuberculosis

Share to Rifampin

Share to Sensitivity and Specificity

Share to Tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 38012619
DOI: 10.1186/s12879-023-08509-0
PMCID: PMC10680243

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF.PMID 38012619Read ↗

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022.Semantic proximity Read ↗

Evaluation of Direct susceptibility testing method for Moxifloxacin against Mycobacterium tuberculosis using the BACTEC MGIT 960 systemSemantic proximity Read ↗

Evaluation of Direct susceptibility testing method for Moxifloxacin against Mycobacterium tuberculosis using the BACTEC MGIT 960 systemSemantic proximity Read ↗

Discordance between genotypic and phenotypic methods for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis and the correlation with patient treatment outcomesSemantic proximity Read ↗

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosisSemantic proximity Read ↗

A novel dual probe-based method for mutation detection using isothermal amplification.Semantic proximity Read ↗

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Semantic proximity Read ↗

Multicenter Noninferiority Evaluation of Hain GenoType MTBDR <i>plus</i> Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid ResistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.